![]() |
|
|
Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.
| 11. | WR Martin, CG Eades, JA Thompson, RE Huppler, PE Gilbert | ||
| The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog | |||
|---|---|---|---|
|
J. Pharmacol. Exp. Ther. Jun 01, 1976; 197: 517-532.
(In "ARTICLES") |
|||
| 12. | Francesca Catella-Lawson, Brendan McAdam, Briggs W. Morrison, Shiv Kapoor, Dean Kujubu, Lisa Antes, Kenneth C. Lasseter, Hui Quan, Barry J. Gertz, Garret A. Fitzgerald | ||
| Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids | |||
|
J. Pharmacol. Exp. Ther. May 01, 1999; 289: 735-741.
(In "ARTICLES") |
|||
| 13. | Mong-Heng Wang, Elimor Brand-Schieber, Barbara A. Zand, Xuandai Nguyen, John R. Falck, Narayanan Balu, Michal Laniado Schwartzman | ||
| Cytochrome P450-Derived Arachidonic Acid Metabolism in the Rat Kidney: Characterization of Selective Inhibitors | |||
|
J. Pharmacol. Exp. Ther. Mar 01, 1998; 284: 966-973.
(In "PROSTAGLANDINS, LEUKOTRIENES AND OTHER EICOSANOIDS") |
|||
| 14. | AM Badger, JN Bradbeer, B Votta, JC Lee, JL Adams, DE Griswold | ||
| Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function | |||
|
J. Pharmacol. Exp. Ther. Dec 01, 1996; 279: 1453-1461.
(In "ARTICLES") |
|||
| 15. | Mary F. Paine, Mehraneh Khalighi, Jeannine M. Fisher, Danny D. Shen, Kent L. Kunze, Christopher L. Marsh, James D. Perkins, Kenneth E. Thummel | ||
| Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism | |||
|
J. Pharmacol. Exp. Ther. Dec 01, 1997; 283: 1552-1562.
(In "DRUG METABOLISM AND DISPOSITION") |
|||
| 16. | M Bourrie, V Meunier, Y Berger, G Fabre | ||
| Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes | |||
|
J. Pharmacol. Exp. Ther. Apr 01, 1996; 277: 321-332.
(In "ARTICLES") |
|||
| 17. | O Laneuville, DK Breuer, DL Dewitt, T Hla, CD Funk, WL Smith | ||
| Differential inhibition of human prostaglandin endoperoxide H synthases- 1 and -2 by nonsteroidal anti-inflammatory drugs | |||
|
J. Pharmacol. Exp. Ther. Nov 01, 1994; 271: 927-934.
(In "ARTICLES") |
|||
| 18. | E Carmeliet | ||
| Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide | |||
|
J. Pharmacol. Exp. Ther. Aug 01, 1992; 262: 809-817.
(In "ARTICLES") |
|||
| 19. | P Patrignani, MR Panara, A Greco, O Fusco, C Natoli, S Iacobelli, F Cipollone, A Ganci, C Creminon, J Maclouf | ||
| Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases | |||
|
J. Pharmacol. Exp. Ther. Dec 01, 1994; 271: 1705-1712.
(In "ARTICLES") |
|||
| 20. | V Gisclard, VM Miller, PM Vanhoutte | ||
| Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit | |||
|
J. Pharmacol. Exp. Ther. Jan 01, 1988; 244: 19-22.
(In "ARTICLES") |
|||
| [Previous 10 Articles] [Next 10 Articles] | |||